A preclinical model to tackle chronic rhinosinusitis.
A preclinical model to tackle chronic rhinosinusitis.
复制标题
解决慢性鼻窦炎的临床前模型。
DOI:
10.1002/alr.22768
复制
发表时间:
2021
影响因子:
6.4
通讯作者:
Douglas,RichardG
中科院分区:
文献类型:
--
作者:
Cho,Do-Yeon;Douglas,RichardG
We were delighted to read the recent article by Schilling and colleagues and we commend the authors for their efforts in quantifying the radiography and histologic findings in this preclinical model. 1 As the authors pointed out in the introduction, chronic rhinosinusitis (CRS) is known to be a multifactorial disease process characterized by impaired mucociliary clearance (MCC) with subsequent compromised microbial elimination. Subsequently, hypoxia due to obstruction of the osteomeatal complex is widely considered one of the major pathogenic mechanisms leading to chronic inflammation, and this is strongly supported by evidence that hypoxia is present at the surface epithelium in diseased sinuses of closed ostia. 2 We have been studying this obstruction-based rabbit model of rhinosinusitis for more than half a decade and would like to comment on several findings in the article.Although no single animal model reproduces all the characteristics of human disease, a well-controlled preclinical model could provide an opportunity to answer the mechanisms in human diseases. Similarities exist between the immunologic features of rabbit and human sinus mucosa and an in vivo rabbit model of acute sinusitis has been established. Thus, we used rabbits as an animal model of chronic inflammation by blocking the sinus outflow tract. 3 We found that the sinus epithelium became infiltrated with acute inflammatory cells (neutrophils) during week 2. When followed for a further 10 to 12 weeks, the animals developed a chronic inflammatory condition by week 14. This obstruction-based rabbit model can provide an unprecedented gateway to study microbial-host interactions with a level of experimental control that is not achievable in humans.